In a showy hearing, Bernie Sanders gets few answers about lower drug prices
In a jam-packed hearing room, Sen. Bernie Sanders pressed CEOs with familiar questions about how expensive drugs are in America.
WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater.
The hearing, featuring Merck CEO Robert Davis, Johnson & Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared. Photographers flocked for photos as Sanders shook hands with each executive, standard practice before such hearings begin.
What's Your Reaction?
